Form 4 for CL Colgate-Palmolive
Accepted 2026-08-07 17:23:39 ET · period of report 2026-08-06 · accession 0001225208-26-007035 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-08-07 17:23 | 2026-08-06 | CL | CAHILL JOHN T | Dir | M - OptEx | $71.56 | +4,170 | 32.5K | +15% | +$298.4K |
| D | 2026-08-07 17:23 | 2026-08-06 | CL | CAHILL JOHN T | Dir | S - Sale+OE | $93.37 | -4,170 | 28.4K | -13% | -$389.4K |
| D | 2026-08-07 17:23 | 2026-08-06 | CL | CAHILL JOHN T | Dir | M - OptEx | $0.00 | -4,170 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-06 | M | A | 4,170 | $71.56 | 32,543 | D | — | — | (F1) Exercise of stock options awarded under the issuer's incentive compensation plan. |
| 2 | Common | Common Stock | 2026-08-06 | S | D | 4,170 | $93.37 | 28,373 | D | — | — | (F2) Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan. (F3) Weighted average price, as these shares were sold in multiple transactions at prices ranging from $93.3712 to $93.39, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 3 | Derivative | Stock Option (Right to Buy) | 2026-08-06 | M | D | 4,170 | $0.00 | 0 | D | $71.56 · — to 2027-05-13 | 4,170 Common Stock | (F1) Exercise of stock options awarded under the issuer's incentive compensation plan. (F4) Option became exercisable in equal annual installments over three years beginning on the first anniversary of the May 13, 2019 grant date. |